In vivo Targeting of Human Neutralizing Antibodies against CD55 and CD59 to Lymphoma Cells Increases the Antitumor Activity of Rituximab
(Q57374767)
scientific article published on 01 November 2007
scientific article published on 01 November 2007
Language:
Current Data About
In vivo Targeting of Human Neutralizing Antibodies against CD55 and CD59 to Lymphoma Cells Increases the Antitumor Activity of Rituximab
other details
description | scientific article published on 01 November 2007 |
External Links
(P356) |
10.1158/0008-5472.CAN-07-1811
|
(P698) |
17975000
|